Summary
In Eisai Co., Ltd. v. Teva Pharmaceuticals. USA, Inc., 131 S. Ct. 2991 (2011), the Supreme Court ordered vacatur for mootness of this court's judgment in Teva Pharmaceuticals. USA, Inc. v. Eisai Co., Ltd., 620 F.3d 1341 (Fed. Cir. 2010).
Summary of this case from Microsoft Corp. v. Int'l Trade Comm'nOpinion
No. 10–1070.
06-13-2011
EISAI CO., LTD., et al., petitioners, v. TEVA PHARMACEUTICALS USA, INC., Through its GATE PHARMACEUTICALS DIVISION.
On petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit. Petition for writ of certiorari granted. Judgment vacated, and case remanded to the United States Court of Appeals for the Federal Circuit with instructions to dismiss the case as moot. See United States v. Munsingwear, Inc., 340 U.S. 36, 71 S.Ct. 104, 95 L.Ed. 36 (1950).